GlassScriptPhysician profile
Jason C Mcbean
NPI 1649492752
$1,754.94
in general payments reported to CMS, 2019-2025
17 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $59.11 · 2021: $66.32 · 2022: $247 · 2023: $283 · 2024: $193 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $316.05 | 2022-2025 | Adbry, Anzupgo |
| Abbvie INC. | $274.75 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $249.25 | 2019-2024 | |
| Galderma Laboratories, L.P. | $242.02 | 2019-2024 | |
| Medtronic Vascular, INC. | $128.48 | 2019 | |
| Janssen Biotech, INC. | $92.37 | 2020-2025 | Tremfya |
| Allergan, INC. | $60.48 | 2019-2022 | |
| Revance Therapeutics, INC. | $60.25 | 2025 | Daxxify |
| Amgen INC. | $54.22 | 2019 | |
| Pfizer INC. | $51.91 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $51.77 | 2019 | |
| Prugen, INC. Pharmaceuticals | $41.34 | 2019 | |
| Arcutis Biotherapeutics, INC. | $41.15 | 2023 | |
| Encore Dermatology INC. | $35.78 | 2019 | |
| Incyte Corporation | $20.19 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.67 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.26 | 2024 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Mcbean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.